文献速递血液净化与透析慢性肾脏病

糖尿病血液透析患者补充益生菌具有有益的代谢效应

Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects.
PubMed 文献 · Kidney Int · 2016-12-04

一项平行随机双盲安慰剂对照临床试验纳入60例糖尿病血液透析患者,随机接受含嗜酸乳杆菌、干酪乳杆菌和双歧杆菌的益生菌胶囊或安慰剂12周。与安慰剂组相比,益生菌组空腹血糖、血清胰岛素、HOMA-IR、HOMA-β、HbA1c、超敏C反应蛋白、丙二醛、主观全面评估评分和总铁结合力显著降低,定量胰岛素敏感性检查指数和血浆总抗氧化能力显著升高。

要点

  • 益生菌组较安慰剂组空腹血糖降低22.0 vs 升高6.6 mg/dl,HbA1c降低0.4 vs 降低0.1%。
  • 益生菌组较安慰剂组HOMA-IR降低2.9 vs 升高2.5,HOMA-β降低14.1 vs 升高6.1。
  • 益生菌组较安慰剂组超敏C反应蛋白降低1933 vs 升高252 ng/ml,丙二醛降低0.3 vs 升高1.0 μmol/l。

核心结论

  • 糖尿病血液透析患者补充益生菌12周对血糖稳态参数及部分炎症和氧化应激生物标志物具有有益效应。

研究设计与样本

  • 平行随机双盲安慰剂对照临床试验,纳入60例糖尿病血液透析患者,按性别、透析和糖尿病病程、体重指数和年龄匹配后随机分为两组。
  • 益生菌组接受含嗜酸乳杆菌、干酪乳杆菌和双歧杆菌的胶囊,安慰剂组接受安慰剂,疗程12周。
  • 基于整个试验期间的三日饮食记录,饮食宏量和微量营养素及总膳食纤维无显著变化,不干扰结果。

主要发现

  • 益生菌组较安慰剂组空腹血浆葡萄糖降低22.0 vs 升高6.6 mg/dl。
  • 益生菌组较安慰剂组血清胰岛素降低6.4 vs 升高2.3 μIU/ml。
  • 益生菌组较安慰剂组HOMA-IR降低2.9 vs 升高2.5,HOMA-β降低14.1 vs 升高6.1。
  • 益生菌组较安慰剂组HbA1c降低0.4 vs 降低0.1%,定量胰岛素敏感性检查指数升高0.03 vs 降低0.02。
  • 益生菌组较安慰剂组超敏C反应蛋白降低1933 vs 升高252 ng/ml,丙二醛降低0.3 vs 升高1.0 μmol/l,主观全面评估评分降低0.7 vs 升高0.7,总铁结合力降低230 vs 升高33 μg/dl,血浆总抗氧化能力升高15 vs 降低88 mmol/l。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study determined the effects of probiotic supplementation on glycemic control, lipid concentrations, biomarkers of inflammation and oxidative stress in 60 diabetic patients on hemodialysis in a parallel randomized double-blind placebo-controlled clinical trial. Participants were initially matched based on sex, duration of dialysis and diabetes, body mass index and age. Subsequently, they were randomly divided into two groups to take either a capsule containing the probiotics Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium bifidum or placebo for 12 weeks. Based on three-day dietary records throughout the trial, there was no significant change in dietary macro- and micro-nutrients or total dietary fiber to confound results. After the 12 weeks, analysis of patients who received probiotic supplements compared with the placebo showed they had significantly decreased fasting plasma glucose (-22.0 vs. +6.6 mg/dl), serum insulin (-6.4 vs. +2.3 μIU/ml), homeostasis model of assessment-estimated insulin resistance (-2.9 vs. +2.5), homeostasis model of assessment-estimated beta-cell function (-14.1 vs. +6.1) and HbA1c (-0.4 vs. -0.1%,), and improved quantitative insulin sensitivity check index (+0.03 vs. -0.02). Additionally, compared with the placebo, probiotic supplementation resulted in significant reductions in serum high-sensitivity C-reactive protein (-1933 vs. +252 ng/ml), plasma malondialdehyde (-0.3 vs. +1.0 μmol/l), subjective global assessment scores (-0.7 vs. +0.7) and total iron binding capacity (-230 vs. +33 μg/dl), and a significant increase in plasma total antioxidant capacity (+15 vs. -88 mmol/l). Thus, probiotic supplementation for 12 weeks among diabetic hemodialysis patients had beneficial effects on parameters of glucose homeostasis, and some biomarkers of inflammation and oxidative stress.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Soleimani A, Zarrati Mojarrad M, Bahmani F, et al. Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney Int. 2016. PMID: 27927601. doi:10.1016/j.kint.2016.09.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。